Vergoeding 2019-2023 voor ATC-subgroep L04AE : Sfingosine-1-fosfaat (s1p) receptormodulatoren
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L04AE01 Fingolimod (Gilenya ®) | 23.131.200 | 21.647.700 | 24.124.400 | 23.138.100 | 18.040.600 |
| L04AE02 Ozanimod (Zeposia ®) | . | 1.441 | 1.240.900 | 4.921.500 | 6.270.700 |
| L04AE03 Siponimod (Mayzent ®) | . | . | 1.364.100 | 3.412.200 | 3.913.100 |
| L04AE04 Ponesimod (Ponvory ®) | . | . | 157 | 494.430 | 3.118.100 |
| Totaal | 23.131.200 | 21.649.141 | 26.729.557 | 31.966.230 | 31.342.500 |